These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15456634)

  • 21. Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study.
    Brink M; Weijenberg MP; de Goeij AF; Roemen GM; Lentjes MH; de Bruïne AP; van Engeland M; Goldbohm RA; van den Brandt PA
    Int J Cancer; 2005 May; 114(5):824-30. PubMed ID: 15609319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
    Slattery ML; Curtin K; Sweeney C; Levin TR; Potter J; Wolff RK; Albertsen H; Samowitz WS
    Int J Cancer; 2007 Feb; 120(3):656-63. PubMed ID: 17096326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive and hormonal factors in male and female colon cancer.
    Kampman E; Bijl AJ; Kok C; van't Veer P
    Eur J Cancer Prev; 1994 Jul; 3(4):329-36. PubMed ID: 7950887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States.
    Kampman E; Potter JD; Slattery ML; Caan BJ; Edwards S
    Cancer Causes Control; 1997 Mar; 8(2):146-58. PubMed ID: 9134238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen and coronary heart disease in women.
    Barrett-Connor E; Bush TL
    JAMA; 1991 Apr; 265(14):1861-7. PubMed ID: 2005736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifestyle factors and Ki-ras mutations in colon cancer tumors.
    Slattery ML; Anderson K; Curtin K; Ma K; Schaffer D; Edwards S; Samowitz W
    Mutat Res; 2001 Nov; 483(1-2):73-81. PubMed ID: 11600135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA).
    Jacobs EJ; White E; Weiss NS
    Cancer Causes Control; 1994 Jul; 5(4):359-66. PubMed ID: 8080948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle and Reproductive Factors and Ovarian Cancer Risk by p53 and MAPK Expression.
    Harris HR; Rice MS; Shafrir AL; Poole EM; Gupta M; Hecht JL; Terry KL; Tworoger SS
    Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):96-102. PubMed ID: 29133366
    [No Abstract]   [Full Text] [Related]  

  • 31. Lifestyle and colon cancer: an assessment of factors associated with risk.
    Slattery ML; Edwards SL; Boucher KM; Anderson K; Caan BJ
    Am J Epidemiol; 1999 Oct; 150(8):869-77. PubMed ID: 10522658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are dietary factors involved in DNA methylation associated with colon cancer?
    Slattery ML; Schaffer D; Edwards SL; Ma KN; Potter JD
    Nutr Cancer; 1997; 28(1):52-62. PubMed ID: 9200151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal and reproductive factors and the risk of bladder cancer in women.
    McGrath M; Michaud DS; De Vivo I
    Am J Epidemiol; 2006 Feb; 163(3):236-44. PubMed ID: 16319290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA; Hoover RN
    Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
    Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer.
    Slattery ML; Sweeney C; Murtaugh M; Ma KN; Wolff RK; Potter JD; Caan BJ; Samowitz W
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2936-42. PubMed ID: 16365013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
    Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of p53 mutations in colon cancer at the population level.
    Samowitz WS; Curtin K; Ma KN; Edwards S; Schaffer D; Leppert MF; Slattery ML
    Int J Cancer; 2002 Jun; 99(4):597-602. PubMed ID: 11992552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.